Literature DB >> 20865533

Docking to large allosteric binding sites on protein surfaces.

Ursula D Ramirez1, Faina Myachina, Linda Stith, Eileen K Jaffe.   

Abstract

The inactive porphobilinogen synthase (PBGS) hexamer has an oligomer-specific and phylogenetically variable surface cavity that is not present in the active octamer. The octamer and hexamer are components of a dynamic quaternary structure equilibrium characteristic of morpheeins. Small molecules that bind to the hexamer-specific surface cavity, which is at the interface of three subunits, are predicted to act as allosteric inhibitors that function by drawing the oligomeric equilibrium toward the hexamer. We used GLIDE as a tool to enrich a 250,000 molecule library for molecules with enhanced probability of acting as hexamer-stabilizing allosteric inhibitors of PBGS from Yersinia enterocolitica. Eighty-six compounds were tested in vitro and five showed hexamer stabilization. We discuss the application of computational docking to surface cavities as an approach to find allosteric modulators of protein function with specific reference to morpheeins that function as an equilibrium of non-additive quaternary structure assemblies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20865533      PMCID: PMC2946403          DOI: 10.1007/978-1-4419-5913-3_54

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  20 in total

1.  The Protein Data Bank.

Authors:  H M Berman; J Westbrook; Z Feng; G Gilliland; T N Bhat; H Weissig; I N Shindyalov; P E Bourne
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

2.  Binding of small molecules to an adaptive protein-protein interface.

Authors:  Michelle R Arkin; Mike Randal; Warren L DeLano; Jennifer Hyde; Tinh N Luong; Johan D Oslob; Darren R Raphael; Lisa Taylor; Jun Wang; Robert S McDowell; James A Wells; Andrew C Braisted
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-11       Impact factor: 11.205

3.  Allosteric proteins and cellular control systems.

Authors:  J MONOD; J P CHANGEUX; F JACOB
Journal:  J Mol Biol       Date:  1963-04       Impact factor: 5.469

4.  Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening.

Authors:  Thomas A Halgren; Robert B Murphy; Richard A Friesner; Hege S Beard; Leah L Frye; W Thomas Pollard; Jay L Banks
Journal:  J Med Chem       Date:  2004-03-25       Impact factor: 7.446

5.  X-ray structure of 5-aminolaevulinate dehydratase, a hybrid aldolase.

Authors:  P T Erskine; N Senior; S Awan; R Lambert; G Lewis; I J Tickle; M Sarwar; P Spencer; P Thomas; M J Warren; P M Shoolingin-Jordan; S P Wood; J B Cooper
Journal:  Nat Struct Biol       Date:  1997-12

Review 6.  The porphobilinogen synthase catalyzed reaction mechanism.

Authors:  Eileen K Jaffe
Journal:  Bioorg Chem       Date:  2004-10       Impact factor: 5.275

7.  An unusual phylogenetic variation in the metal ion binding sites of porphobilinogen synthase.

Authors:  Eileen K Jaffe
Journal:  Chem Biol       Date:  2003-01

8.  Structure of porphobilinogen synthase from Pseudomonas aeruginosa in complex with 5-fluorolevulinic acid suggests a double Schiff base mechanism.

Authors:  Frederic Frère; Wolf-Dieter Schubert; Frédéric Stauffer; Nicole Frankenberg; Reinhard Neier; Dieter Jahn; Dirk W Heinz
Journal:  J Mol Biol       Date:  2002-07-05       Impact factor: 5.469

9.  Control of tetrapyrrole biosynthesis by alternate quaternary forms of porphobilinogen synthase.

Authors:  Sabine Breinig; Jukka Kervinen; Linda Stith; Andrew S Wasson; Robert Fairman; Alexander Wlodawer; Alexander Zdanov; Eileen K Jaffe
Journal:  Nat Struct Biol       Date:  2003-08-03

10.  Allosteric inhibition of human porphobilinogen synthase.

Authors:  Sarah H Lawrence; Ursula D Ramirez; Trevor Selwood; Linda Stith; Eileen K Jaffe
Journal:  J Biol Chem       Date:  2009-12-18       Impact factor: 5.157

View more
  10 in total

1.  Impact of quaternary structure dynamics on allosteric drug discovery.

Authors:  Eileen K Jaffe
Journal:  Curr Top Med Chem       Date:  2013       Impact factor: 3.295

2.  The morpheein model of allostery: evaluating proteins as potential morpheeins.

Authors:  Eileen K Jaffe; Sarah H Lawrence
Journal:  Methods Mol Biol       Date:  2012

Review 3.  Allostery and the dynamic oligomerization of porphobilinogen synthase.

Authors:  Eileen K Jaffe; Sarah H Lawrence
Journal:  Arch Biochem Biophys       Date:  2011-10-19       Impact factor: 4.013

4.  Systematic discovery of molecular probes targeting multiple non-orthosteric and spatially distinct sites in the botulinum neurotoxin subtype A (BoNT/A).

Authors:  Saedeh Dadgar; Wely B Floriano
Journal:  Mol Cell Probes       Date:  2015-03-04       Impact factor: 2.365

5.  A new model for allosteric regulation of phenylalanine hydroxylase: implications for disease and therapeutics.

Authors:  Eileen K Jaffe; Linda Stith; Sarah H Lawrence; Mark Andrake; Roland L Dunbrack
Journal:  Arch Biochem Biophys       Date:  2013-01-11       Impact factor: 4.013

6.  Environmental contaminants perturb fragile protein assemblies and inhibit normal protein function.

Authors:  Sarah H Lawrence; Trevor Selwood; Eileen K Jaffe
Journal:  Curr Chem Biol       Date:  2013

Review 7.  Porphobilinogen synthase: An equilibrium of different assemblies in human health.

Authors:  Eileen K Jaffe
Journal:  Prog Mol Biol Transl Sci       Date:  2019-12-06       Impact factor: 3.622

8.  Re-Exploring the Ability of Common Docking Programs to Correctly Reproduce the Binding Modes of Non-Covalent Inhibitors of SARS-CoV-2 Protease Mpro.

Authors:  Davide Bassani; Matteo Pavan; Giovanni Bolcato; Mattia Sturlese; Stefano Moro
Journal:  Pharmaceuticals (Basel)       Date:  2022-01-31

Review 9.  Targeting the C-Terminal Domain Small Phosphatase 1.

Authors:  Harikrishna Reddy Rallabandi; Palanivel Ganesan; Young Jun Kim
Journal:  Life (Basel)       Date:  2020-05-08

10.  Repurposing of FDA-approved drugs against active site and potential allosteric drug-binding sites of COVID-19 main protease.

Authors:  Merve Yuce; Erdem Cicek; Tugce Inan; Aslihan Basak Dag; Ozge Kurkcuoglu; Fethiye Aylin Sungur
Journal:  Proteins       Date:  2021-07-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.